How the patent system and the FDA discourage study of cancer prevention

from The Incidental Economist at on December 30, 2015 at 12:00PM

The following originally appeared on The Upshot (copyright 2015, The New York Times Company). Most people would agree that it would be better to prevent cancer, if we could, than to treat it once it developed. Yet economic incentives encourage researchers to focus on treatment rather than prevention. The way the patent system interacts with the Food […]